Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meiragtx Holdings Plc (MGTX)
NASDAQ:MGTX
Holding MGTX?
Track your performance easily
MGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.85 - $7.60
Previous Close$6.15
Volume1.20M
Average Volume (3M)313.81K
Market Cap
$480.64M
Enterprise Value$444.51M
Total Cash (Recent Filing)$122.87M
Total Debt (Recent Filing)$86.73M
Price to Earnings (P/E)―
Beta2.69
Next Earnings
Mar 12, 2025EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.30
Shares Outstanding78,153,401
10 Day Avg. Volume272,762
30 Day Avg. Volume313,811
Standard Deviation0.18
R-Squared0.14
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)5.04
Price to Sales (P/S)34.50
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.05K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.93
Forecast
1Y Price Target
$16.33Price Target Upside165.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Meiragtx Holdings News
PremiumCompany Announcements
MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves
PremiumCompany Announcements
MeiraGTx Holdings Reports Promising Parkinson’s Therapy ResultsRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
MGTX FAQ
What was Meiragtx Holdings Plc’s price range in the past 12 months?
Meiragtx Holdings Plc lowest stock price was $3.85 and its highest was $7.60 in the past 12 months.
What is Meiragtx Holdings Plc’s market cap?
Currently, no data Available
When is Meiragtx Holdings Plc’s upcoming earnings report date?
Meiragtx Holdings Plc’s upcoming earnings report date is Mar 12, 2025 which is in 75 days.
How were Meiragtx Holdings Plc’s earnings last quarter?
Meiragtx Holdings Plc released its earnings results on Nov 13, 2024. The company reported -$0.55 earnings per share for the quarter, beating the consensus estimate of -$0.563 by $0.013.
Is Meiragtx Holdings Plc overvalued?
According to Wall Street analysts Meiragtx Holdings Plc’s price is currently Undervalued.
Does Meiragtx Holdings Plc pay dividends?
Meiragtx Holdings Plc does not currently pay dividends.
What is Meiragtx Holdings Plc’s EPS estimate?
Meiragtx Holdings Plc’s EPS estimate is -$0.53.
How many shares outstanding does Meiragtx Holdings Plc have?
Meiragtx Holdings Plc has 78,153,404 shares outstanding.
What happened to Meiragtx Holdings Plc’s price movement after its last earnings report?
Meiragtx Holdings Plc reported an EPS of -$0.55 in its last earnings report, beating expectations of -$0.563. Following the earnings report the stock price went up 5.706%.
Which hedge fund is a major shareholder of Meiragtx Holdings Plc?
Among the largest hedge funds holding Meiragtx Holdings Plc’s share is Perceptive Advisors LLC. It holds Meiragtx Holdings Plc’s shares valued at 52M.
---
Meiragtx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.33 (165.53% Upside)
$16.33 (165.53% Upside)
Blogger Sentiment
Bullish
MGTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.25%
12-Months-Change
Fundamentals
Return on Equity
-93.99%
Trailing 12-Months
Asset Growth
12.09%
Trailing 12-Months
Company Description
Meiragtx Holdings Plc
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
---
MGTX Stock 12 Month Forecast
Average Price Target
$16.33
▲(165.53% Upside)
Technical Analysis
Adverum Biotechnologies
―
Crispr Therapeutics AG
―
Editas Medicine
―
Intellia Therapeutics
―
Best Analysts Covering MGTX
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-11.60%
reiterated a buy rating last month
Copying Luca Issi's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -11.60% per trade.
---